Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease
Annals of Neurology · 2026-06 · 99 (6) · 1415-1427
DOI: 10.1002/ana.78202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 10.03.2026. Verfasst von Yue Jing Heng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Substantia Nigra, Parkinson Disease, Dopaminergic Neurons, Ferroptosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education Singapore Academic Research Fund; Lee Kong Chian School of Medicine Strategic Academic Initiative award.
Abstract (Originalsprache)
Objective
The extent of neuronal loss in Parkinson's disease (PD) and the pathogenic processes underlying neuronal dysfunction and loss remain poorly understood. Here, we analyzed the expression of key molecules representing different cell death signaling pathways and their association with Lewy pathology, dopaminergic (DA) neuron loss and stage of PD progression in human postmortem brain tissue.
Methods
We performed neuropathological and molecular analyses on 47 postmortem substantia nigra (SN) tissue samples from PD cases and healthy controls to investigate neuronal cell death pathways.
Results
An average loss of 54% of dopaminergic neurons was found in the SN of PD cases, which correlated strongly with PD Braak staging. The apoptosis markers, cleaved subunits of caspases 3 and 8, were absent. Levels of the active necroptosis kinase, phosphorylated RIPK3 (pRIPK3), were significantly increased in advanced‐stage PD. Although phosphorylated MLKL (pMLKL) levels were not significantly different, both active markers were detected in small numbers of PD neurons by immunofluorescence, suggesting focal necroptotic pathway activation. In contrast, evidence for ferroptosis was more pronounced, particularly in advanced‐stage PD. This was supported by significantly increased transferrin receptor 1 (TFR1) protein levels and significantly decreased glutathione peroxidase 4 (GPX4) RNA and protein levels.
Interpretation
Our findings implicate ferroptosis, and to a lesser extent necroptosis, in PD neuronal death, with ferroptosis potentially playing a larger role in advanced disease. We propose a “2‐hit” model where early synucleinopathy‐driven insults are amplified in advanced disease by a neuromelanin‐iron‐driven feedback loop, establishing ferroptosis as the predominant cell death mechanism. This stage‐dependent shift provides critical insights into PD pathogenesis and suggests distinct therapeutic windows for neuroprotection. ANN NEUROL 2026;99:1415–1427
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- National Neuroscience Institute, Singapore, Singapore.
- Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.
ORCID-Profile: Yue Jing Heng, Anusha Jayaraman, Richard Reynolds, Jia Nee Foo
Förderung
- Ministry of Education Singapore Academic Research Fund; Lee Kong Chian School of Medicine Strategic Academic Initiative award
Zitieren
APA
Heng, Y. J., Jayaraman, A., Reynolds, R., & Foo, J. N. (2026). Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease. Annals of Neurology, 99(6), 1415-1427. https://doi.org/10.1002/ana.78202
Vancouver
Heng YJ, Jayaraman A, Reynolds R, Foo JN. Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease. Annals of Neurology. 2026;99(6):1415-1427. doi:10.1002/ana.78202
BibTeX
@article{Heng2026,
author = {Heng, Yue Jing and Jayaraman, Anusha and Reynolds, Richard and Foo, Jia Nee},
title = {Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease},
journal = {Annals of Neurology},
year = {2026},
volume = {99},
number = {6},
pages = {1415--1427},
doi = {10.1002/ana.78202}
}
EUVIMED